NDC 17271-703
3% Sodium Chloride
3% Sodium Chloride
3% Sodium Chloride is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Becton Dickinson And Company. The primary component is Sodium Chloride.
| Product ID | 17271-703_ab3d79da-7b4a-4224-b0e4-46bd00bf6444 |
| NDC | 17271-703 |
| Product Type | Human Prescription Drug |
| Proprietary Name | 3% Sodium Chloride |
| Generic Name | 3% Sodium Chloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-02-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209476 |
| Labeler Name | Becton Dickinson and Company |
| Substance Name | SODIUM CHLORIDE |
| Active Ingredient Strength | 3 g/100mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |